ESSA Pharma Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ESSA Pharma Inc EPIX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 6.75 0.00 0.00 0.00 6.75 04:00:00
Bid Price Ask Price Spread Spread % News
6.50 8.00 1.50 18.75% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 6.75 USD

ESSA Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 195.68M 28.99M 13.48M $ - $ - -1.24 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ESSA Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EPIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.806.976.206.7454,443-0.05-0.74%
1 Month6.127.315.9356.67168,0840.6310.29%
3 Months4.997.314.366.3384,5561.7635.27%
6 Months5.357.313.005.7755,9201.4026.17%
1 Year1.677.311.46215.1047,9385.08304.19%
3 Years0.367.310.102.0552,7146.391,775.0%
5 Years6.507.750.101.8543,8610.253.85%

ESSA Pharma Description

ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Your Recent History
ESSA Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.